Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair M. smegmatis Growth and Disturb Chromosome Replication-Reference-Cited by-同舟云学术

Amsacrine Derivatives Selectively Inhibit Mycobacterial Topoisomerase I (TopA), Impair M. smegmatis Growth and Disturb Chromosome Replication

Published:2018-07-17 Issue: Volume:9 Page:
ISSN:1664-302X
Container-title:Frontiers in Microbiology
language:
Short-container-title:Front. Microbiol.

Author:

Szafran Marcin J.,Kołodziej Marta,Skut Patrycja,Medapi Brahmam,Domagała Agnieszka,Trojanowski Damian,Zakrzewska-Czerwińska Jolanta,Sriram Dharmarajan,Jakimowicz Dagmara

Publisher

Frontiers Media SA

Subject

Microbiology (medical),Microbiology

Reference42 articles.

1. Carboxyl terminal domain basic amino acids of mycobacterial topoisomerase I bind DNA to promote strand passage;Ahmed;Nucleic Acids Res.,2013

2. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review;Avalos;PloS ONE,2015

3. Hypernegative supercoiling inhibits growth by causing RNA degradation;Baaklini;J. Bacteriol.,2008

4. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy;Bailly;Chem. Rev.,2012

5. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2);Bentley;Nature,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterial IHF is a highly dynamic nucleoid-associated protein that assists HupB in organizing chromatin;Frontiers in Microbiology;2023-03-07

2. ABT-MPNN: an atom-bond transformer-based message-passing neural network for molecular property prediction;Journal of Cheminformatics;2023-02-26

3. Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in Mycobacterium tuberculosis;Science Advances;2022-11-25

4. The DNA-topoisomerase Inhibitors in Cancer Therapy;Biomedical and Pharmacology Journal;2022-06-30

5. Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells;European Journal of Medicinal Chemistry;2022-05